GFL Ltd

Q2 FY19 Earnings Call Analysis

Finance

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 4margin: Category 3orderbook: No information
💰

fundraise

Any current/future new fundraising through debt or equity?

- For FY 2020, Gujarat Fluorochemicals Limited (GFL2) has a capital expenditure (CAPEX) cash flow of about Rs. 125 crores yet to be incurred. - Rs. 25 crores of CAPEX was incurred in Q1 FY 2020. - There is no explicit mention of any current or future plans for fundraising through debt or equity in the document. - GFL2 currently holds a net cash position of approximately Rs. 158 crores as of April 1, 2019. - The company expects its revenue streams (e.g., from specialty chemicals, fluoro-polymers) to increase, potentially supporting organic growth. - No additional fundraising initiatives such as new debt or equity issuances were disclosed in the conference call excerpts provided.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- For GFL2 (Gujarat Fluorochemicals Limited, chemical business), FY 2020 capex yet to be incurred is about Rs. 125 crores. - Rs. 25 crores of capex was incurred in Q1 FY 2020. - There is an indication that the Rs. 37 crores per quarter run rate in some business segments is sustainable and expected to increase going forward. - Capital advances given for building a wind power IPP (Inox Wind Infrastructure) suggest ongoing strategic investment, intended to be flipped to third-party investors in 12-18 months. - Other investments in subsidiaries such as INOX Leisure, INOX Wind, and Renewable businesses are held by GFL1 and include strategic stakes valued at several hundred crores. Further demergers and structural decisions regarding these investments are to be evaluated and announced.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Specialty chemicals segment is expected to grow with the addition of 9 to 10 new molecules in the current year, reaching about 11 to 12 molecules by year-end. (Page 16) - Revenue run rate for specialty fluoro-intermediates (~Rs. 37 crores per quarter) and new fluoro-polymers is sustainable and anticipated to increase going forward. (Page 16) - Fluoropolymer segment volumes for Q1 FY20 were about 4,000 tonnes; demand shows some sluggishness mainly due to the European automobile sector slowdown, but expected to improve. (Page 15) - Prices of key raw materials (fluorspar and chloroform) had increased by 20-25%; expected to reduce over the next 2-3 quarters, potentially improving margins and growth. (Pages 17, 14) - Value-added products sales grew 30% YoY, with new fluoro-polymers up 54%, indicating strong growth momentum in higher-margin segments. (Page 12) - Overall, volumes and revenues in specialty chemicals and fluoro-polymer segments are expected to grow steadily, supporting future sales growth. (Pages 15-17)
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Specialty chemicals segment expected to expand with addition of 9-10 new molecules in the year, targeting a total of 11-12 molecules by year end (Page 16). - Fluoro-polymers and specialty fluoro intermediates sales slated to grow continuously quarter-on-quarter (Page 16). - New fluoro-polymers and fluoro-monomers posted 54% growth in Q1 FY 2020, indicating robust growth potential (Page 12). - EPS and PAT growth expected to sustain with PAT margin improving (15.2% in Q1 FY 2020), though Q1 included a tax write back of Rs. 32 crores that is non-recurring (Page 12). - Raw material price pressures caused gross margin contraction; however, a reduction in raw material costs is expected over the next 2-3 quarters, which could improve margins (Pages 14, 17). - Run rates for specialty chemicals (Rs. 37 crores per quarter) and fluoro-polymers expected to sustain and increase over time (Page 16). - Some segment-specific pricing pressures noted (e.g., refrigerants in U.S.), but overall demand for fluoropolymers and intermediates showing positive momentum (Page 16).
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The transcript provided does not explicitly mention current or expected orderbook or pending orders for Gujarat Fluorochemicals Limited. - There is discussion on volumes like PTFE sales (~4,000 tonnes in a quarter) and some sluggish demand due to European automobile sector slowdown. - Specialty chemicals portfolio is expanding, with 11-12 molecules expected by year-end, adding 9-10 molecules this year. - No specific data or commentary on orderbook or pending orders was shared during the Q&A or management commentary in this transcript. - Management focused more on pricing, raw material cost pressures, segmental performance, and structural changes post-demerger rather than order inflow or backlog details. If you require, I can help summarize other financial or operational highlights from the call.